TY - JOUR
T1 - CSWG-SCAI Stages Combined With Machine Learning–Based Phenotypes for Serial Risk Stratification in Cardiogenic Shock
AU - CSWG Academic Research Consortium
AU - Zweck, Elric
AU - Ton, Van Khue
AU - Kanwar, Manreet
AU - Li, Song
AU - Li, Borui
AU - Sinha, Shashank S.
AU - Hernandez-Montfort, Jaime
AU - Garan, A. Reshad
AU - Abraham, Jacob
AU - Blumer, Vanessa
AU - Kataria, Rachna
AU - Polzin, Amin
AU - Burkhoff, Daniel
AU - Kapur, Navin K.
AU - Hickey, Gavin W.
AU - Pahuja, Mohit
AU - Lundgren, Scott
AU - Nathan, Sandeep
AU - Vorovich, Esther
AU - Hall, Shelley
AU - Khalife, Wissam
AU - Schwartzman, Andrew
AU - Kim, Ju
AU - Vishnevsky, Oleg Alec
AU - Fried, Justin
AU - Farr, Mary Jane
AU - Mishkin, Joseph
AU - Chang, I. H.
AU - Ilonze, Onyedika
AU - Arias, Alexandra
AU - Nakata, Jun
AU - Marbach, Jeffery
AU - Bezerra, Hiram
AU - Gage, Ann
AU - Wald, Joyce
AU - Thomas, Sunu
AU - Kochar, Ajar
AU - Vallabhajosyula, Saraschandra
AU - Mahr, Claudius
AU - Rahman, Faisal
AU - Masoumi, Amirali
AU - Gohar, Salman
AU - John, Kevin
AU - Kong, Qiuyue
AU - Sangal, Paavni
AU - Walec, Karol D.
AU - Zazzali, Peter
AU - Harwani, Neil M.
N1 - Publisher Copyright:
© 2025
PY - 2025/10
Y1 - 2025/10
N2 - Background: Cardiogenic shock (CS) severity can be defined by the SCAI (Society for Cardiovascular Angiography and Interventions) stages (A to E), or machine learning–based phenotypes (I: noncongested, II: cardiorenal, III: cardiometabolic). Objectives: This study aims to evaluate sequential applicability and prognostic relevance of combining SCAI stages and ML-based phenotypes for risk stratification of patients with CS. Methods: The authors retrospectively applied both classification systems at 6- to 12-hour intervals for the first 72 hours to patients from the multicenter CSWG (Cardiogenic Shock Working Group) registry. The primary outcome was in-hospital mortality. Results: A total of 7,716 CS patients were included (admission CSWG-SCAI stages A to E: n = 1,526, n = 1,602, n = 838, n = 2,445, and n = 1,305, respectively; phenotypes I to III: n = 2,963, n = 3,266, n = 1,487, respectively). Within 6 hours from admission, CSWG-SCAI stages and phenotypes changed in 78% and 77% of patients, respectively, then remained relatively unchanged throughout the first 72 hours. Combining ML-based phenotypes with CSWG-SCAI stages to subclassify patients improved risk stratification (mortality for stages C-I: 12%-14%, C-II: 22%-26%, D-I: 21%-23%, D-II: 31%-34%, and D-III: 37%-40%). Admission phenotypes II and III strongly increased the odds of CS progression from stages A-C to D-E or death within 72 hours of admission (phenotype II: OR: 1.2 [95% CI: 0.99-1.39]; P = 0.051; phenotype III: OR: 11.4 [95% CI: 3.50-36.95]; P < 0.0001). Conclusions: Most patients with CS reached phenotype I and stage D within 6 hours after admission. Combining ML-based phenotypes with CSWG-SCAI staging may facilitate the transition from typical treatment intensity–based approaches to mechanistic classification that reflects the heterogeneity within CS populations.
AB - Background: Cardiogenic shock (CS) severity can be defined by the SCAI (Society for Cardiovascular Angiography and Interventions) stages (A to E), or machine learning–based phenotypes (I: noncongested, II: cardiorenal, III: cardiometabolic). Objectives: This study aims to evaluate sequential applicability and prognostic relevance of combining SCAI stages and ML-based phenotypes for risk stratification of patients with CS. Methods: The authors retrospectively applied both classification systems at 6- to 12-hour intervals for the first 72 hours to patients from the multicenter CSWG (Cardiogenic Shock Working Group) registry. The primary outcome was in-hospital mortality. Results: A total of 7,716 CS patients were included (admission CSWG-SCAI stages A to E: n = 1,526, n = 1,602, n = 838, n = 2,445, and n = 1,305, respectively; phenotypes I to III: n = 2,963, n = 3,266, n = 1,487, respectively). Within 6 hours from admission, CSWG-SCAI stages and phenotypes changed in 78% and 77% of patients, respectively, then remained relatively unchanged throughout the first 72 hours. Combining ML-based phenotypes with CSWG-SCAI stages to subclassify patients improved risk stratification (mortality for stages C-I: 12%-14%, C-II: 22%-26%, D-I: 21%-23%, D-II: 31%-34%, and D-III: 37%-40%). Admission phenotypes II and III strongly increased the odds of CS progression from stages A-C to D-E or death within 72 hours of admission (phenotype II: OR: 1.2 [95% CI: 0.99-1.39]; P = 0.051; phenotype III: OR: 11.4 [95% CI: 3.50-36.95]; P < 0.0001). Conclusions: Most patients with CS reached phenotype I and stage D within 6 hours after admission. Combining ML-based phenotypes with CSWG-SCAI staging may facilitate the transition from typical treatment intensity–based approaches to mechanistic classification that reflects the heterogeneity within CS populations.
KW - acute myocardial infarction
KW - artificial intelligence
KW - cardiogenic shock
KW - heart failure
KW - machine learning
KW - mechanical circulatory support
KW - mortality
KW - phenotypes
UR - https://www.scopus.com/pages/publications/105013224471
UR - https://www.scopus.com/pages/publications/105013224471#tab=citedBy
U2 - 10.1016/j.jchf.2025.102611
DO - 10.1016/j.jchf.2025.102611
M3 - Article
C2 - 40840206
AN - SCOPUS:105013224471
SN - 2213-1779
VL - 13
JO - JACC: Heart Failure
JF - JACC: Heart Failure
IS - 10
M1 - 102611
ER -